BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27281577)

  • 1. Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patients.
    Liu Z; Matsuzawa Y; Herrmann J; Li J; Lennon RJ; Crusan DJ; Kwon TG; Zhang M; Sun T; Yang S; Gulati R; Bell MR; Lerman LO; Lerman A
    Int J Cardiol; 2016 Sep; 219():56-62. PubMed ID: 27281577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome.
    Masrani Mehta S; Depta JP; Novak E; Patel JS; Patel Y; Raymer D; Facey G; Zajarias A; Lasala JM; Singh J; Bach RG; Kurz HI
    J Am Heart Assoc; 2015 Aug; 4(8):e002172. PubMed ID: 26289346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve).
    Ahn JM; Park DW; Shin ES; Koo BK; Nam CW; Doh JH; Kim JH; Chae IH; Yoon JH; Her SH; Seung KB; Chung WY; Yoo SY; Lee JB; Choi SW; Park K; Hong TJ; Lee SY; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ;
    Circulation; 2017 Jun; 135(23):2241-2251. PubMed ID: 28356440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.
    Kennedy MW; Hermanides RS; Kaplan E; Hemradj V; Fabris E; Koopmans PC; Dambrink JE; Gosselink AT; Van't Hof AW; Ottervanger JP; Roolvink V; Remkes WS; van der Sluis A; Suryapranata H; Kedhi E
    Am J Cardiol; 2016 Nov; 118(9):1293-1299. PubMed ID: 27614852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes in Patients with Deferred Coronary Lesions according to Disease Severity Assessed by Fractional Flow Reserve.
    Won KB; Nam CW; Cho YK; Yoon HJ; Park HS; Kim H; Han S; Hur SH; Kim YN; Park SH; Han JK; Koo BK; Kim HS; Doh JH; Lee SY; Yang HM; Lim HS; Yoon MH; Tahk SJ; Kim KB
    J Korean Med Sci; 2016 Dec; 31(12):1929-1936. PubMed ID: 27822931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment.
    Depta JP; Patel JS; Novak E; Gage BF; Masrani SK; Raymer D; Facey G; Patel Y; Zajarias A; Lasala JM; Amin AP; Kurz HI; Singh J; Bach RG
    Eur Heart J; 2015 Feb; 36(8):509-15. PubMed ID: 25336221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus.
    Kennedy MW; Kaplan E; Hermanides RS; Fabris E; Hemradj V; Koopmans PC; Dambrink JH; Marcel Gosselink AT; Van't Hof AW; Ottervanger JP; Roolvink V; Remkes WS; van der Sluis A; Suryapranata H; Kedhi E
    Cardiovasc Diabetol; 2016 Jul; 15():100. PubMed ID: 27431395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
    Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve values.
    Depta JP; Patel JS; Novak E; Masrani SK; Raymer D; Facey G; Patel Y; Zajarias A; Lasala JM; Singh J; Bach RG; Kurz HI
    Am J Cardiol; 2014 Jun; 113(11):1788-93. PubMed ID: 24837255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in Long-Term Outcomes in Patients With Deferred Revascularization Following Fractional Flow Reserve Assessment: International Collaboration Registry of Comprehensive Physiologic Evaluation.
    Hoshino M; Hamaya R; Kanaji Y; Kanno Y; Hada M; Yamaguchi M; Sumino Y; Hirano H; Horie T; Usui E; Sugiyama T; Murai T; Lee T; Yonetsu T; Lee JM; Choi KH; Hwang D; Park J; Jung JH; Kim HY; Jung HW; Cho YK; Yoon HJ; Song YB; Hahn JY; Doh JH; Nam CW; Shin ES; Hur SH; Mejía-Rentería H; Lauri F; Goto S; Macaya F; McInerney A; Gravina G; Vera R; Gonzalo N; Jimenez-Quevedo P; Nuñez-Gil I; Salinas P; Nombela-Franco L; Del Trigo M; Fernández-Ortiz A; Macaya C; Koo BK; Escaned J; Kakuta T
    J Am Heart Assoc; 2020 Feb; 9(4):e014458. PubMed ID: 32063120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes According to Fractional Flow Reserve or Instantaneous Wave-Free Ratio in Deferred Lesions.
    Lee JM; Shin ES; Nam CW; Doh JH; Hwang D; Park J; Kim KJ; Zhang J; Ahn C; Koo BK
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2502-2510. PubMed ID: 29198458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Patient-Related and Lesion-Related Outcomes After Real-World Fractional Flow Reserve Use.
    Doh JH; Nam CW; Koo BK; Park SH; Lee JH; Han JK; Yang HM; Lim HS; Yoon MH; Cho YK; Hur SH; Lee SY; Kim HS; Tahk SJ
    J Invasive Cardiol; 2015 Sep; 27(9):410-5. PubMed ID: 26332875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Routine Fractional Flow Reserve Evaluation During Coronary Angiography on Management Strategy and Clinical Outcome: One-Year Results of the POST-IT.
    Baptista SB; Raposo L; Santos L; Ramos R; Calé R; Jorge E; Machado C; Costa M; Infante de Oliveira E; Costa J; Pipa J; Fonseca N; Guardado J; Silva B; Sousa MJ; Silva JC; Rodrigues A; Seca L; Fernandes R
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: A meta-analysis.
    Bundhun PK; Gupta C; Huang F
    Medicine (Baltimore); 2017 Nov; 96(46):e8748. PubMed ID: 29145326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term prognosis in diabetic patients in whom revascularization is deferred following fractional flow reserve assessment].
    Domínguez-Franco AJ; Jiménez-Navarro MF; Muñoz-García AJ; Alonso-Briales JH; Hernández-García JM; de Teresa Galván E
    Rev Esp Cardiol; 2008 Apr; 61(4):352-9. PubMed ID: 18405515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions.
    Weerts J; Pustjens T; Amin E; Ilhan M; Veenstra LF; Theunissen RALJ; Vainer J; Stein M; Ruiters LAW; Gho BCG; Van't Hof AWJ; Rasoul S
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):247-256. PubMed ID: 31999077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary Flow Reserve.
    Kim J; Shin D; Lee JM; Lee SH; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ; van de Hoef TP;
    JACC Cardiovasc Interv; 2022 May; 15(10):1033-1043. PubMed ID: 35490124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus.
    Kennedy MW; Fabris E; Hermanides RS; Kaplan E; Borren N; Berta B; Koopmans PC; Ottervanger JP; Suryapranata H; Kedhi E
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1077-1083. PubMed ID: 28303683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Diabetic Patients.
    Alkhalil M; McCune C; McClenaghan L; Mailey J; Collins P; Kearney A; Todd M; McKavanagh P
    Cardiovasc Revasc Med; 2020 Jul; 21(7):897-902. PubMed ID: 31883978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of drug eluting stents on cardiovascular events in patients with intermediate lesions and borderline fractional flow reserve.
    Lavi S; Rihal CS; Yang EH; Fassa AA; Elesber A; Lennon RJ; Mathew V; David HR; Lerman A
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):525-31. PubMed ID: 17896397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.